Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT04178967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel-group study which is 52 weeks in duration. The study is designed to confirm the safety and efficacy of lebrikizumab as monotherapy for treatment of moderate-to-severe atopic dermatitis utilizing a 16-week induction treatment period and a 36-week long-term maintenance treatment period.
Study identification
- NCT ID
- NCT04178967
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 445 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2019 (Actual)
- Primary completion
- Jul 12, 2021 (Actual)
- Completion
- Apr 28, 2022 (Actual)
- Last update posted
- May 24, 2023
2019 – 2022
United States locations
- U.S. sites
- 40
- U.S. states
- 20
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigate MD | Scottsdale | Arizona | 85255 | — |
| Northwest Arkansas Clinical Trials Center | Rogers | Arkansas | 72758 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Woodward Centre | Fresno | California | 93720 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| LA Universal Research Center, INC | Los Angeles | California | 90057 | — |
| University Clinical Trials, Inc. | San Diego | California | 92123 | — |
| San Luis Dermatology & Laser Clinic | San Luis Obispo | California | 93405 | — |
| Clinical Physiology Associates, Clinical Study Center | Fort Myers | Florida | 33916-9452 | — |
| Direct Helpers Medical Center | Hialeah | Florida | 33012 | — |
| The Community Research of South Florida | Hialeah | Florida | 33016 | — |
| Solutions Through Advanced Research, Inc. | Jacksonville | Florida | 32256 | — |
| Georgia Pollens Clinical Research Centers, Inc | Albany | Georgia | 31707 | — |
| Marietta Dermatology Clinical Research | Marietta | Georgia | 30060 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| NorthShore University HealthSystem | Skokie | Illinois | 60077 | — |
| Kansas City Dermatology, PA | Overland Park | Kansas | 66215 | — |
| Meridian Clinical Research | Baton Rouge | Louisiana | 70808 | — |
| ActivMed Practices and Research | Beverly | Massachusetts | 01915 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Clarkston Skin Research | Clarkston | Michigan | 48346 | — |
| Associated Skin Care Specialists | Fridley | Minnesota | 55432 | — |
| Central Dermatology PC | St Louis | Missouri | 63117 | — |
| Forest Hills Dermatology Group | Kew Gardens | New York | 11415 | — |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28405 | — |
| Dermatology and Skin Surgery Center | Exton | Pennsylvania | 19341 | — |
| DermDOX | Hazleton | Pennsylvania | 18201 | — |
| Peak Research LLC | Upper Saint Clair | Pennsylvania | 15241 | — |
| Dermatology & Laser Center of Charleston | Charleston | South Carolina | 29407 | — |
| Palmetto Clinical Trial Services | Greenville | South Carolina | 29601 | — |
| Arlington Research Center, Inc | Arlington | Texas | 76011 | — |
| Innovate Research, LLC | Fort Worth | Texas | 76244 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| University of Utah MidValley Dematology | Murray | Utah | 84107 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04178967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04178967 live on ClinicalTrials.gov.